BCAT1 and central nervous system cancer: In gliomas, lincRNA00963 reduces the expression level of miR-506, thereby affecting the downstream target protein branched-chain Amino Acid Transaminase 1 (BCAT1) and weakening the inhibitory effect of miR-506 on tumors (63).